SynopsisGemtuzumab ozogamicin is a drug-linked monoclonal antibody (an antibody-drug conjugate) that was used to treat acute myeloid leukemia from 2000 to 2010. The global Gemtuzumab Ozogamicin market size is expected to reach US$ 179.5 million by 2029, growing .....
SynopsisThe global Cold Plasma Technology market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Cold Plasma Technology in various end use industries. The expanding.....
SynopsisThe Keratosis Pilaris Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market play.....
SynopsisIndwelling intravascular access devices (catheters) provide a route for: administering fluids, blood products, nutrients and intravenous medications; monitoring haemodynamic function; maintaining emergency vascular access; and obtaining blood specimens. Intrav.....
SynopsisThe Impression Materials market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, va.....
SynopsisThe global Wheeled Walkers market was valued at US$ million in 2020 and is expected to reach US$ million by the end of 2027, growing at a CAGR of % during 2021-2027. This report focuses on Wheeled Walkers volume and value at the global level, regional.....
SynopsisBlood monitor machines employ oscillometric measurements and electronic calculations rather than auscultation. They may use automatic inflation, but both types are electronic, easy to operate without training, and can be used in noisy environments. The g.....
SynopsisThe global Neuro Stimulation Devices market was valued at US$ 13610 million in 2023 and is anticipated to reach US$ 16910 million by 2030, witnessing a CAGR of 3.1% during the forecast period 2024-2030. North American market for Neuro Stimulation Devices.....
SynopsisCabozantinib, sold under the brand-name Cabometyx and Cometriq, is a medication used to treat medullary thyroid cancer and a second line treatment for renal cell carcinoma among others. It is a small molecule inhibitor of the tyrosine kinases c-Met and VEGFR2,.....
Synopsis The global Nasal Lavage market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. North American market for Nasal Lavage is estimated to incre.....
